Clostridioides Difficile Infection
📧 Sign up to get email alerts when something new happens for Clostridioides Difficile Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: A Multi-center, Single-arm Trial Exploring the Safety and Clinical Effectiveness of RBX2660 Administered by Colonoscopy to Adults With Recurrent Clostridioides Difficile Infection [Phase 3]
Phase 3, multi-center, single-arm trial evaluating RBX2660 delivered by colonoscopy in adults with recurrent Clostridioides difficile infect…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older [Phase 3]
Pfizer is conducting a Phase 3 clinical trial to evaluate a Clostridioides difficile vaccine in adults 65 years and older with Clostridioide…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Multi-omics Dissection of Gut Microbiome Engraftment During FMT [NA]
Clinical trial update for a NOT_YET_RECRUITING study examining gut microbiome engraftment during fecal microbiota transplantation in recurre…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: VE303 for Prevention of Recurrent Clostridioides Difficile Infection [Phase 3]
Phase 3 clinical trial VE303 to prevent recurrence of Clostridioides difficile infection is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Vancomycin for C Difficile NAAT+/EIA- Hematology Oncology Patients [Phase 2]
Phase 2 trial evaluating vancomycin for NAAT+/EIA- Clostridioides difficile infection in patients with hematologic diseases, including bone …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Fecal Microbiome Transplant [Phase 1]
This is a Phase 1 clinical trial update on fecal microbiome transplantation that is currently enrolling by invitation for patients with Clos…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Study of Factors Influencing the Dynamics of Colonisation and Decolonisation of the Digestive Tract by Clostridioides Difficile in Infants [NA]
A clinical trial exploring factors that influence how Clostridioides difficile colonizes and decolonizes the infant digestive tract.
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: High- Fiber/ Low-fat Diet for Prevention of Recurrent Clostridioides Difficile Infection in Oncology [NA]
A completed clinical trial examined whether a high-fiber, low-fat diet can prevent recurrent Clostridioides difficile infection in oncology …
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: ACX-362E [Ibezapolstat] for Oral Treatment of Recurrent Clostridioides Difficile Infection [Phase 2]
A Phase 2 clinical trial of ACX-362E (ibezapolstat) for recurrent Clostridioides difficile infection is listed as not yet recruiting.
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody [Phase 2]
Phase 2 study evaluating AZD5148 monoclonal antibody to prevent recurrent Clostridioides difficile infection is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Intestinal Microbiota Transplantation in Patients Undergoing Colon Resection [Phase 1]
Phase 1 trial evaluating fecal microbiota transplantation in patients undergoing colon resection; the study is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Effect of Oral Microbiota on MDRO Decolonization [Phase 1, Phase 2]
This clinical trial explored whether altering the oral microbiota can promote decolonization of multidrug-resistant organisms in participant…
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: Fecal Microbiota Transplant [Phase 4]
A Phase 4 clinical trial evaluating fecal microbiota transplant for Clostridioides difficile infection has completed.
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: FMT in Patients With Recurrent CDI and Ulcerative Colitis: Single Infusion Versus Sequential Approach [Phase 1, Phase 2]
This clinical trial update reports an ongoing Phase 1/2 study comparing single infusion versus sequential fecal microbiota transplantation i…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Changes in Recipients Gut Microbiota After Fecal Microbiota Transplantation
This clinical trial update investigates how recipients' gut microbiota change after fecal microbiota transplantation in the context of preve…
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: SYN-004 Safety and Tolerability in Allo-HCT Subjects [Phase 1, Phase 2]
Phase 1/Phase 2 trial evaluating safety and tolerability of SYN-004 in adults undergoing allogeneic hematopoietic stem cell transplantation,…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Fecal Microbiota Transplantation (FMT): PRIM-DJ2727
Clinical trial update on PRIM-DJ2727 fecal microbiota transplantation for recurrent Clostridioides difficile infection and multidrug-resista…
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: FMT Capsules for rCDI [Phase 3]
Phase 3 trial evaluating fecal microbiota transplant capsules for recurrent Clostridioides difficile infection, currently not recruiting.
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: REMBRANDT: REcovery of the MicroBiome fRom Antibiotics for Dental implanTs
The REMBRANDT trial investigates recovery of the oral microbiome after antibiotic exposure in dental implant patients, sponsored by the Univ…
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: Bezlotoxumab Yielded Outcomes by Addressing Personalized Needs in Clostridioides Difficile Infection [Phase 2]
A Phase 2 trial of bezlotoxumab for Clostridioides difficile infection examined outcomes tailored to personalized patient needs, with result…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Pre-emptive Prevention for Patients at High Risk for Hospital-onset Clostridioides Difficile [NA]
A clinical trial is evaluating pre-emptive prevention for patients at high risk of hospital-onset Clostridioides difficile infection and is …
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Evaluation of EXL01, a New Live Biotherapeutic Product to Prevent Recurrence of Clostridioides Difficile Infection in High-risk Patients [Phase 1, Phase 2]
A clinical trial update for EXL01, a live biotherapeutic product intended to prevent recurrence of Clostridioides difficile infection in hig…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Xylitol Use for Decolonization of C. Difficile in Patients With IBD [Phase 1]
A Phase 1 study is investigating whether xylitol can decolonize Clostridioides difficile in patients with inflammatory bowel disease. The tr…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Outcomes and Data Collection for Fecal Microbiota Transplantation for the Treatment of Recurrent Clostridium Difficile [NA]
An ongoing clinical trial is evaluating fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile infection, …
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: LMN-201 for Prevention of C. Difficile Infection Recurrence [Phase 2, Phase 3]
LMN-201 is being evaluated to prevent recurrence of Clostridioides difficile infection in Phase 2/Phase 3 trials, and recruitment is ongoing…